Adjusted Financial Ratios (Summary)
Adjusted Total Asset Turnover
Adjusted Current Ratio
Adjusted Debt to Equity
Adjusted Debt to Capital
Adjusted Financial Leverage
Adjusted Net Profit Margin
Adjusted Return on Equity (ROE)
Adjusted Return on Assets (ROA)

Eli Lilly & Co., adjusted financial ratios

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Activity Ratio
Total Asset Turnover
Reported	0.57	0.53	0.58	0.58	0.53
Adjusted	0.64	0.58	0.61	0.61	0.56
Liquidity Ratio
Current Ratio
Reported	1.15	0.94	1.05	1.23	1.40
Adjusted	1.15	0.94	1.05	1.23	1.40
Solvency Ratios
Debt to Equity
Reported	2.37	2.34	1.52	1.88	2.94
Adjusted	5.53	4.87	2.10	2.09	3.39
Debt to Capital
Reported	0.70	0.70	0.60	0.65	0.75
Adjusted	0.85	0.83	0.68	0.68	0.77
Financial Leverage
Reported	5.55	5.94	4.65	5.44	8.27
Adjusted	11.22	10.82	5.78	5.52	8.61
Profitability Ratios
Net Profit Margin
Reported	23.51%	15.36%	21.88%	19.71%	25.24%
Adjusted	17.65%	6.81%	16.04%	24.47%	24.88%
Return on Equity (ROE)
Reported	74.62%	48.65%	58.64%	62.16%	109.79%
Adjusted	126.28%	42.98%	56.67%	82.62%	120.07%
Return on Assets (ROA)
Reported	13.45%	8.19%	12.62%	11.44%	13.28%
Adjusted	11.25%	3.97%	9.80%	14.97%	13.94%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Financial ratio	Description	The company
Adjusted total asset turnover	An activity ratio calculated as total revenue divided by adjusted total assets.	Eli Lilly & Co. adjusted total asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.
Adjusted current ratio	A liquidity ratio calculated as adjusted current assets divided by adjusted current liabilities.	Eli Lilly & Co. adjusted current ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.
Adjusted debt-to-equity ratio	A solvency ratio calculated as adjusted total debt divided by adjusted total equity.	Eli Lilly & Co. adjusted debt-to-equity ratio deteriorated from 2022 to 2023 and from 2023 to 2024.
Adjusted debt-to-capital ratio	A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity.	Eli Lilly & Co. adjusted debt-to-capital ratio deteriorated from 2022 to 2023 and from 2023 to 2024.
Adjusted financial leverage	A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity. Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.	Eli Lilly & Co. adjusted financial leverage ratio increased from 2022 to 2023 and from 2023 to 2024.
Adjusted net profit margin	An indicator of profitability, calculated as adjusted net income divided by total revenue.	Eli Lilly & Co. adjusted net profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.
Adjusted ROE	A profitability ratio calculated as adjusted net income divided by adjusted total equity.	Eli Lilly & Co. adjusted ROE deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.
Adjusted ROA	A profitability ratio calculated as adjusted net income divided by adjusted total assets.	Eli Lilly & Co. adjusted ROA deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.

Eli Lilly & Co., Financial Ratios: Reported vs. Adjusted

Download chart

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Reported
Selected Financial Data (US$ in thousands)
Revenue	45,042,700)	34,124,100)	28,541,400)	28,318,400)	24,539,800)
Total assets	78,714,900)	64,006,300)	49,489,800)	48,806,000)	46,633,100)
Activity Ratio
Total asset turnover¹	0.57	0.53	0.58	0.58	0.53
Adjusted
Selected Financial Data (US$ in thousands)
Revenue	45,042,700)	34,124,100)	28,541,400)	28,318,400)	24,539,800)
Adjusted total assets²	70,666,300)	58,441,400)	46,704,000)	46,305,000)	43,793,800)
Activity Ratio
Adjusted total asset turnover³	0.64	0.58	0.61	0.61	0.56

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

¹ 2024 Calculation
Total asset turnover = Revenue ÷ Total assets
= 45,042,700 ÷ 78,714,900 = 0.57

² Adjusted total assets. See details »

³ 2024 Calculation
Adjusted total asset turnover = Revenue ÷ Adjusted total assets
= 45,042,700 ÷ 70,666,300 = 0.64

Download chart

Activity ratio	Description	The company
Adjusted total asset turnover	An activity ratio calculated as total revenue divided by adjusted total assets.	Eli Lilly & Co. adjusted total asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Reported
Selected Financial Data (US$ in thousands)
Current assets	32,739,700)	25,727,000)	18,034,500)	18,452,400)	17,462,100)
Current liabilities	28,376,600)	27,293,200)	17,138,200)	15,052,700)	12,481,600)
Liquidity Ratio
Current ratio¹	1.15	0.94	1.05	1.23	1.40
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted current assets²	32,691,700)	25,639,400)	18,041,600)	18,440,700)	17,453,200)
Current liabilities	28,376,600)	27,293,200)	17,138,200)	15,052,700)	12,481,600)
Liquidity Ratio
Adjusted current ratio³	1.15	0.94	1.05	1.23	1.40

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

¹ 2024 Calculation
Current ratio = Current assets ÷ Current liabilities
= 32,739,700 ÷ 28,376,600 = 1.15

² Adjusted current assets. See details »

³ 2024 Calculation
Adjusted current ratio = Adjusted current assets ÷ Current liabilities
= 32,691,700 ÷ 28,376,600 = 1.15

Download chart

Liquidity ratio	Description	The company
Adjusted current ratio	A liquidity ratio calculated as adjusted current assets divided by adjusted current liabilities.	Eli Lilly & Co. adjusted current ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Reported
Selected Financial Data (US$ in thousands)
Total debt	33,644,200)	25,225,300)	16,238,600)	16,884,700)	16,595,300)
Total Eli Lilly and Company shareholders’ equity	14,192,100)	10,771,900)	10,649,800)	8,979,200)	5,641,600)
Solvency Ratio
Debt to equity¹	2.37	2.34	1.52	1.88	2.94
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt²	34,790,800)	26,330,100)	16,966,800)	17,570,400)	17,259,000)
Adjusted total equity³	6,296,900)	5,402,700)	8,076,800)	8,387,200)	5,085,800)
Solvency Ratio
Adjusted debt to equity⁴	5.53	4.87	2.10	2.09	3.39

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

¹ 2024 Calculation
Debt to equity = Total debt ÷ Total Eli Lilly and Company shareholders’ equity
= 33,644,200 ÷ 14,192,100 = 2.37

² Adjusted total debt. See details »

³ Adjusted total equity. See details »

⁴ 2024 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted total equity
= 34,790,800 ÷ 6,296,900 = 5.53

Download chart

Solvency ratio	Description	The company
Adjusted debt-to-equity ratio	A solvency ratio calculated as adjusted total debt divided by adjusted total equity.	Eli Lilly & Co. adjusted debt-to-equity ratio deteriorated from 2022 to 2023 and from 2023 to 2024.

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Reported
Selected Financial Data (US$ in thousands)
Total debt	33,644,200)	25,225,300)	16,238,600)	16,884,700)	16,595,300)
Total capital	47,836,300)	35,997,200)	26,888,400)	25,863,900)	22,236,900)
Solvency Ratio
Debt to capital¹	0.70	0.70	0.60	0.65	0.75
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt²	34,790,800)	26,330,100)	16,966,800)	17,570,400)	17,259,000)
Adjusted total capital³	41,087,700)	31,732,800)	25,043,600)	25,957,600)	22,344,800)
Solvency Ratio
Adjusted debt to capital⁴	0.85	0.83	0.68	0.68	0.77

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

¹ 2024 Calculation
Debt to capital = Total debt ÷ Total capital
= 33,644,200 ÷ 47,836,300 = 0.70

² Adjusted total debt. See details »

³ Adjusted total capital. See details »

⁴ 2024 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= 34,790,800 ÷ 41,087,700 = 0.85

Download chart

Solvency ratio	Description	The company
Adjusted debt-to-capital ratio	A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity.	Eli Lilly & Co. adjusted debt-to-capital ratio deteriorated from 2022 to 2023 and from 2023 to 2024.

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Reported
Selected Financial Data (US$ in thousands)
Total assets	78,714,900)	64,006,300)	49,489,800)	48,806,000)	46,633,100)
Total Eli Lilly and Company shareholders’ equity	14,192,100)	10,771,900)	10,649,800)	8,979,200)	5,641,600)
Solvency Ratio
Financial leverage¹	5.55	5.94	4.65	5.44	8.27
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total assets²	70,666,300)	58,441,400)	46,704,000)	46,305,000)	43,793,800)
Adjusted total equity³	6,296,900)	5,402,700)	8,076,800)	8,387,200)	5,085,800)
Solvency Ratio
Adjusted financial leverage⁴	11.22	10.82	5.78	5.52	8.61

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

¹ 2024 Calculation
Financial leverage = Total assets ÷ Total Eli Lilly and Company shareholders’ equity
= 78,714,900 ÷ 14,192,100 = 5.55

² Adjusted total assets. See details »

³ Adjusted total equity. See details »

⁴ 2024 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted total equity
= 70,666,300 ÷ 6,296,900 = 11.22

Download chart

Solvency ratio	Description	The company
Adjusted financial leverage	A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity. Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.	Eli Lilly & Co. adjusted financial leverage ratio increased from 2022 to 2023 and from 2023 to 2024.

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Reported
Selected Financial Data (US$ in thousands)
Net income	10,590,000)	5,240,400)	6,244,800)	5,581,700)	6,193,700)
Revenue	45,042,700)	34,124,100)	28,541,400)	28,318,400)	24,539,800)
Profitability Ratio
Net profit margin¹	23.51%	15.36%	21.88%	19.71%	25.24%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income²	7,951,600)	2,322,300)	4,576,900)	6,929,900)	6,106,300)
Revenue	45,042,700)	34,124,100)	28,541,400)	28,318,400)	24,539,800)
Profitability Ratio
Adjusted net profit margin³	17.65%	6.81%	16.04%	24.47%	24.88%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

¹ 2024 Calculation
Net profit margin = 100 × Net income ÷ Revenue
= 100 × 10,590,000 ÷ 45,042,700 = 23.51%

² Adjusted net income. See details »

³ 2024 Calculation
Adjusted net profit margin = 100 × Adjusted net income ÷ Revenue
= 100 × 7,951,600 ÷ 45,042,700 = 17.65%

Download chart

Profitability ratio	Description	The company
Adjusted net profit margin	An indicator of profitability, calculated as adjusted net income divided by total revenue.	Eli Lilly & Co. adjusted net profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Reported
Selected Financial Data (US$ in thousands)
Net income	10,590,000)	5,240,400)	6,244,800)	5,581,700)	6,193,700)
Total Eli Lilly and Company shareholders’ equity	14,192,100)	10,771,900)	10,649,800)	8,979,200)	5,641,600)
Profitability Ratio
ROE¹	74.62%	48.65%	58.64%	62.16%	109.79%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income²	7,951,600)	2,322,300)	4,576,900)	6,929,900)	6,106,300)
Adjusted total equity³	6,296,900)	5,402,700)	8,076,800)	8,387,200)	5,085,800)
Profitability Ratio
Adjusted ROE⁴	126.28%	42.98%	56.67%	82.62%	120.07%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

¹ 2024 Calculation
ROE = 100 × Net income ÷ Total Eli Lilly and Company shareholders’ equity
= 100 × 10,590,000 ÷ 14,192,100 = 74.62%

² Adjusted net income. See details »

³ Adjusted total equity. See details »

⁴ 2024 Calculation
Adjusted ROE = 100 × Adjusted net income ÷ Adjusted total equity
= 100 × 7,951,600 ÷ 6,296,900 = 126.28%

Download chart

Profitability ratio	Description	The company
Adjusted ROE	A profitability ratio calculated as adjusted net income divided by adjusted total equity.	Eli Lilly & Co. adjusted ROE deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Reported
Selected Financial Data (US$ in thousands)
Net income	10,590,000)	5,240,400)	6,244,800)	5,581,700)	6,193,700)
Total assets	78,714,900)	64,006,300)	49,489,800)	48,806,000)	46,633,100)
Profitability Ratio
ROA¹	13.45%	8.19%	12.62%	11.44%	13.28%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income²	7,951,600)	2,322,300)	4,576,900)	6,929,900)	6,106,300)
Adjusted total assets³	70,666,300)	58,441,400)	46,704,000)	46,305,000)	43,793,800)
Profitability Ratio
Adjusted ROA⁴	11.25%	3.97%	9.80%	14.97%	13.94%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

¹ 2024 Calculation
ROA = 100 × Net income ÷ Total assets
= 100 × 10,590,000 ÷ 78,714,900 = 13.45%

² Adjusted net income. See details »

³ Adjusted total assets. See details »

⁴ 2024 Calculation
Adjusted ROA = 100 × Adjusted net income ÷ Adjusted total assets
= 100 × 7,951,600 ÷ 70,666,300 = 11.25%

Download chart

Profitability ratio	Description	The company
Adjusted ROA	A profitability ratio calculated as adjusted net income divided by adjusted total assets.	Eli Lilly & Co. adjusted ROA deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level.

Eli Lilly & Co. (NYSE:LLY)

Adjusted Financial Ratios

Adjusted Financial Ratios (Summary)

Eli Lilly & Co., Financial Ratios: Reported vs. Adjusted

Adjusted Total Asset Turnover

Adjusted Current Ratio

Adjusted Debt to Equity

Adjusted Debt to Capital

Adjusted Financial Leverage

Adjusted Net Profit Margin

Adjusted Return on Equity (ROE)

Adjusted Return on Assets (ROA)